Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma
Clinical trial NCT05346809 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05346809
- Sponsor
- Divaya Bhutani
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-31
- Primary completion
- 2027-07-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.